Clinical decision support software designed to enable effective and efficient care decisions across the oncology care continuum.
A cloud-based solution that enhances the efficiency of multidisciplinary tumor board meetings.
A clinical next-generation sequencing reporting solution that can help labs accurately and efficiently interpret the clinical significance of mutations.
A cloud-based next-generation sequencing secondary analysis solution that efficiently and accurately identifies variants for Roche reagents.
A universal platform to manage cases and view, organize, retrieve and integrate digital tissue images.
A seamless, secure way to track, manage and share important healthcare test results.
Being designed to enable timely and optimal therapy based on guidelines for patients with serious infections.
*Product in development and not commercially available.
As physicians and their clinical staff prioritize remote care management, proactive assessment of cancer patients is critical. Despite difficult circumstances, clinicians continue to pursue innovative ways of providing personalized cancer care.
Homegrown solutions made tumor board processes time consuming and cumbersome. The hospital needed a streamlined, faster approach. Hospital del Mar implemented NAVIFY Tumor Board for its breast cancer tumor boards.
Ten subspecialty tumor boards relied on legacy technologies and data from diverse sources, manually searched and added to PowerPoint presentations. MU needed an updated, better process.
Roche is an Industrial Age entrepreneur, an innovator in cancer care and biomedical research and a leader in in vitro diagnostics — building toward its vision of personalized healthcare.
We endeavor to drive toward a better future for patients by offering data-focused, patient-centric and value-based personalized healthcare.
Find the latest news and events related to NAVIFY portfolio. Read all about the latest collaborations, tools and research that help improve personalized care.
Back
Go to Products overview
NAVIFY Oncology Hub
NAVIFY Tumor Board
Apps for NAVIFY Tumor Board
NAVIFY Mutation Caller
NAVIFY Mutation Profiler
Apps for NAVIFY Mutation Profiler
NAVIFY Digital Pathology
NAVIFY Pass
NAVIFY Infection Management
Go to Why NAVIFY
Back to “Why NAVIFY”
Go to Improving patients’ experience overview
Go to optimizing clinical decision-making overview
Go to Innovating healthcare IT overview
Improving patients’ experience
Optimizing clinical decision-making
Innovating healthcare IT
Reducing time to treatment
Increasing clinical trial enrollment
Improving patient communication
Managing the data avalanche
Rethinking multidisciplinary collaboration
Streamlining tumor board preparation
Supporting guidelines compliance
Integrating disparate data sources
Rationalizing SaaS
Future-proofing institutional IT
Security & privacy
Integration & implementation
Improving Quality of Care through Systems & Data
Simplifying KPI Tracking & Reporting
Operationalizing Value-Based Care
Go to Stories overview
Clinician stories
Hospital del Mar, Barcelona, Spain
Ellis Fischel Cancer Center University of Missouri (MU)
Go to About Us overview
Roche heritage
Vision & mission
News & events
Please have someone from NAVIFY Mutation Profiler team contact me.
You will be redirected to another site. Do you want to continue?